➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Johnson and Johnson
Dow
Colorcon
Harvard Business School

Last Updated: October 27, 2021

DrugPatentWatch Database Preview

Lannett Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LANNETT, and what generic and branded alternatives to LANNETT drugs are available?

LANNETT has two hundred and seven approved drugs.

There is one tentative approval on LANNETT drugs.

Drugs and US Patents for Lannett

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride INJECTABLE;INJECTION 090883-001 Aug 5, 2010 DISCN No No ⤷  Try it Free ⤷  Try it Free
Lannett Co Inc MONOKET isosorbide mononitrate TABLET;ORAL 020215-002 Jun 30, 1993 AB RX Yes No ⤷  Try it Free ⤷  Try it Free
Lannett LANIAZID isoniazid TABLET;ORAL 080140-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
Lannett Co Inc MORPHINE SULFATE morphine sulfate SOLUTION;ORAL 202309-001 Nov 25, 2015 DISCN No No ⤷  Try it Free ⤷  Try it Free
Lannett Co Inc BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 205022-001 Sep 19, 2016 AB RX No No ⤷  Try it Free ⤷  Try it Free
Lannett Co Inc PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 078281-001 Jan 20, 2011 AB RX No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Lannett

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lannett Co Inc METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-003 May 27, 2003 6,344,215 ⤷  Try it Free
Lannett Co Inc MYKROX metolazone TABLET;ORAL 019532-001 Oct 30, 1987 4,517,179 ⤷  Try it Free
Lannett Co Inc METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-002 Jun 19, 2003 6,344,215 ⤷  Try it Free
Lannett Co Inc METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-001 Apr 3, 2001 6,344,215 ⤷  Try it Free
Lannett Co Inc METADATE CD methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259-004 Feb 19, 2006 6,344,215 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for LANNETT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Capsules 10 mg, 20 mg and 30 mg ➤ Subscribe 2005-05-13
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
➤ Subscribe Extended-release Capsules 40 mg ➤ Subscribe 2007-03-15
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Medtronic
Boehringer Ingelheim
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.